Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Targeting Mitochondrial Ion Channels to Fight Cancer
Magdalena Bachmann1, Roberto Costa2, Roberta Peruzzo3
1Department of Biology, University of Padova, 35131 Padova, Italy. magdalena.bachmann@studenti.unipd.it.
Abstract:
In recent years, several experimental evidences have underlined a new role of ion channels in cancer development and progression. In particular, mitochondrial ion channels are arising as new oncological targets, since it has been proved that most of them show an altered expression during tumor development and the pharmacological targeting of some of them have been demonstrated to be able to modulate cancer growth and progression, both in vitro as well as in vivo in pre-clinical mouse models. In this scenario, pharmacology of mitochondrial ion channels would be in the near future a new frontier for the treatment of tumors. In this review, we discuss the new advances in the field, by focusing our attention on the improvements in new drug developments to target mitochondrial ion channels.
Insights
Mitochondrial ion channels are crucial in cancer progression and represent promising new therapeutic targets. Research is advancing drug development for targeting these channels to treat tumors effectively.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Ion channels play a newly recognized role in cancer development and progression.
- Mitochondrial ion channels are increasingly identified as significant oncological targets.
- Altered expression of mitochondrial ion channels is observed during tumor development.
Purpose of the Study:
- To review recent advances in targeting mitochondrial ion channels for cancer treatment.
- To highlight improvements in drug development for these novel oncological targets.
Main Methods:
- Review of experimental evidence and pre-clinical studies.
- Analysis of in vitro and in vivo data on mitochondrial ion channel modulation.
- Focus on advancements in pharmacological strategies.
Main Results:
- Mitochondrial ion channels show altered expression in tumors.
- Pharmacological targeting of these channels can modulate cancer growth and progression.
- Pre-clinical models demonstrate the efficacy of targeting mitochondrial ion channels.
Conclusions:
- Mitochondrial ion channels are emerging as key players in cancer.
- Targeting mitochondrial ion channels offers a promising new frontier for cancer therapy.
- Continued drug development in this area is critical for future tumor treatments.
Related Concept Videos
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Mechanically-gated Ion Channels
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
G-Protein Gated Ion Channels
Sensory...

